Activity value 76china Supplier,Last transaction date:
2026-08-26
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for yichang sanxia pharmaceuticals co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 53 transactions, with a transaction quantity of 40068.32 and a transaction weight of 213806.2.
Product description
NEOMYCIN SULPHATE (Neomycin sulfat) current EP. Nguyên liệu dùng để sản xuất thuốc thuộc mục 668 danh mục 7 TT09. Lô: 202603035, MFG: 01.04.2026, Re-test date: 31.03.2030. Số lượng: 80 BOU = 120 KG
Expand
Trade date
2026/07/18
B/L No.
——
Suppliers
yichang sanxia pharmaceuticals co.ltd.
Buyers
m s glaxosmithkline pakistan ltd.
POLs
——
PODs
kapw
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
20847.489652
Hs code
29419090
Product tags
raw material,r pharm,drap,neomycin sulphate
Product description
RAW MATERIAL FOR PHARMA INDUSTRY NEOMYCIN SULPHATE BP/USP/EP DRAP NOC # 000496 / 000900. DT 08-07-2026
Expand
Hs code
29419090
Product tags
pharmaceutical raw material,neomycin sulphate
Product description
PHARMACEUTICAL RAW MATERIALS : NEOMYCIN SULPHATE USP
Expand
Trade date
2026/06/29
B/L No.
——
Suppliers
yichang sanxia pharmaceuticals co.ltd.
Buyers
m s glaxosmithkline pakistan ltd.
POLs
——
PODs
kapw
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
20387.572815
Hs code
29419090
Product tags
raw material,r pharm,drap,price,kga,cro,unit,neomycin sulphate
Product description
RAW MATERIAL FOR PHARMA INDUSTRY NEOMYCIN SULPHATE (MICRONIZED) BP 2017 / USP 42 QTY 210 KGA UNIT PRICE 95 PER KGA DRAP NOC # 011223 / 009880 DT 03-06-2026
Expand
Product description
NEOMYCIN SULPHATE (NEOMYCIN SULFATE) USP2026 (Dược chất sản xuất thuốc); Số lô: 202604027; NSX: T04/2026-HSD: T04/2029. Hàng mới 100%
Expand
yichang sanxia pharmaceuticals co.ltd. is china Supplier,
and primarily engages in the import and export business of products such as neomycin sulphate,drum,pharmaceutical raw material.
According to the 52wmb.com global trade database, as of 2026-08-26, the company has completed 1543 international trades,
with its main trading regions covering india,united states,pakistan etc.
The core products include HS29419050,HS29419090,HS29419000 etc,
often transported via shanghai,port shanghai cn, port 57035, shanghai etc,
and its main trading partners are bimeda inc,glaxosmithkline pharma gmbh,glaxosmithkline paksitan ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on yichang sanxia pharmaceuticals co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.